All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| HARP / Harpoon Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
| TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RPTX / Repare Therapeutics Inc.
|
|
|
|
|
|
|
|
| IWM / iShares Trust - iShares Russell 2000 ETF Put
|
|
|
|
|
|
|
|
| TBPH / Theravance Biopharma, Inc.
|
|
|
|
|
|
|
|
| US62857M1053 / MyoKardia, Inc.
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US28249H1041 / Eidos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
| KDMN / Kadmon Holdings Inc
|
|
|
|
|
|
|
|
| OMER / Omeros Corporation
|
|
|
|
|
|
|
|
| QURE / uniQure N.V.
|
|
|
|
|
|
|
|
| NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| IGMS / IGM Biosciences, Inc.
|
|
|
|
|
|
|
|
| TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SRNE / Sorrento Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
| TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
| ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
| MYOV / Myovant Sciences Ltd
|
|
|
|
|
|
|
|
| BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
| FVAM / 5:01 Acquisition Corp.
|
|
|
|
|
|
|
|
| MASS / 908 Devices Inc.
|
|
|
|
|
|
|
|
| ALGS / Aligos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| BBIO / BridgeBio Pharma, Inc.
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SPY / SPDR S&P 500 ETF Put
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
| FMTX / Forma Therapeutics Holdings Inc
|
|
|
|
|
|
|
|
| ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
| QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
| KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
| / Cerevel Therapeutics Holdings, Inc. Warrant
|
|
|
|
|
|
|
|
| INSP / Inspire Medical Systems, Inc.
|
|
|
|
|
|
|
|
| GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CABA / Cabaletta Bio, Inc.
|
|
|
|
|
|
|
|
| NTLA / Intellia Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
| US9266131005 / Viela Bio, Inc.
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TCDA / Tricida Inc
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| / Therapeutics Acquisition Corp. Class A
|
|
|
|
|
|
|
|
| DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
| / Vesper Healthcare Acquisition Corp. Unit
|
|
|
|
|
|
|
|
| GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| BNTX / BioNTech SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| GMTX / Gemini Therapeutics Inc
|
|
|
|
|
|
|
|
| FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
| FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SPRY / ARS Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CRDF / Cardiff Oncology, Inc.
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| OTLK / Outlook Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc Call
|
|
|
|
|
|
|
|
| AVRO / AVROBIO, Inc.
|
|
|
|
|
|
|
|
| SRNE / Sorrento Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AVEO / AVEO Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
| AKUS / Akouos Inc
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
| ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ALLK / Allakos Inc.
|
|
|
|
|
|
|
|
| IMV / IMV Inc
|
|
|
|
|
|
|
|
| AVIR / Atea Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
| XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GLTO / Galecto, Inc.
|
|
|
|
|
|
|
|
| PLRX / Pliant Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
| OMER / Omeros Corporation Call
|
|
|
|
|
|
|
|
| AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
| AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
| REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
| TPTX / Turning Point Therapeutics Inc
|
|
|
|
|
|
|
|
| RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
| TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OLMA / Olema Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
| PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
